ロード中...
Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis
BACKGROUND: Programmed cell death ligand 1 (PD-L1) has already been detected in various carcinomas. In non-Hodgkin lymphoma (NHL), however, the prognostic value of PD-L1 overexpression remains unclear. METHODS: A meta-analysis of 2321 NHL patients from 12 studies was performed. Hazard ratios (HRs) w...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6986088/ https://ncbi.nlm.nih.gov/pubmed/31992262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6550-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|